Abstract: A cascade-based power dissipation optimization method and system for an amplification circuit are provided. The method includes: S1, acquiring a relationship of power dissipation of an amplification circuit to input signal amplitudes and voltage gains by means of statistical analysis; and S2, designing an optimal cascade strategy for the amplification circuit according to the relationship of the power dissipation of the amplification circuit to the input signal amplitudes and the voltage gains, and adjusting the number of stages of the amplification circuit and a voltage gain of each stage of the amplification circuit so as to minimize total power dissipation of the amplification circuit.

Abstract: A method for optimizing a mobile phone terminal based on a probability of an energy consumption-related interruption is disclosed. The method includes: S1. predicting a probability of an energy consumption-related interruption in real time; and S2. adjusting an operating frequency of a baseband chip of a mobile phone terminal according to the predicted probability of an energy consumption-related interruption.

Abstract: A method for optimizing a mobile phone terminal based on a probability of an energy consumption-related interruption is disclosed. The method includes: S1. predicting a probability of an energy consumption-related interruption in real time; and S2. adjusting an operating frequency of a baseband chip of a mobile phone terminal according to the predicted probability of an energy consumption-related interruption.

Abstract: The present invention provides a serum-free polypeptide composition for promoting proliferation of mesenchymal stem cells. The composition mainly comprises: 10-100 ?g/L of tripeptide-1; 1-20 ?g/L of tripeptide-2, 1-20 ?g/L of hexapeptide-9, 1-20 ?g/L of palmitoyl hexapeptide-12; and 10-100 ?g/L of a laminin-derived peptide. The serum-free polypeptide composition provided in the present disclosure has clear chemical components without animal origins or serum, can achieve rapid proliferation of the mesenchymal stem cells, and maintains the biological characteristics and immunophenotypic stability of the mesenchymal stem cells while solving the problem of the insufficient quantity of cells.

Abstract: The present invention relates to the field of stem cell technology, and in particular to a stem cell preparation and its application in the preparation of drugs for the treatment of osteoarthritis (OA). The composition provided by the invention can significantly improve the activity of umbilical cord mesenchymal stem cells under cryopreservation conditions, and the stem cell preparation prepared therefrom has a good effect on repairing cartilage injury caused by OA, thereby playing a role in the treatment of OA.

Abstract: The present invention discloses a method for capturing drug targets, comprising the following steps of: (1) preparing row materials, i.e.

Abstract: The present invention discloses a method for capturing drug targets, comprising the following steps of: (1) preparing row materials, i.e.

Abstract: The present invention discloses a cell-penetrating method for compounds, comprising the following steps of: (1) preparing raw materials, i.e., the compounds and DNA or RNA; (2) linking: linking the compounds to the DNA or RNA to obtain a molecular conjugate; and (3) transferring: transferring the molecular conjugate obtained in the step (2) into cells by a gene transfer method. The present invention further discloses a structure of a molecular conjugate for transmembrane transfer and a method for synthesizing the molecular conjugate. The method of the present invention effectively solves a problem of low membrane permeability of compounds, so that the compounds enter the cell to act on targets thereof, thus to provide a novel drug-delivery way. The method of the present invention may be used for clinical treatment by drugs with low membrane permeability.

Abstract: The present invention provides a compound drug-delivery precursor for membrane permeation, and a drug carrier preparation based on this precursor. The compound drug-delivery precursor and the drug carrier preparation of the present invention may effectively improve the membrane permeability of compounds with low membrane permeability and provide a new choice for clinical medication.

Abstract: A method for synthesizing and screening a lead compound, comprising the following steps: (1) retrieving raw materials: retrieving an i-number of synthetic blocks and an (i+2)-number of single-stranded DNA fragments; (2) synthesizing a compound by using a combinatorial chemistry method, acquiring a library of a single-stranded DNA-marked compound; (3) screening: screening the library of the DNA-marked compound; and, (4) sequencing: retrieving the DNA-marked compound screened in step (3), and sequencing the DNA on the DNA-marked compound, where the synthesis blocks and reaction mechanism of the compound can be determined on the basis of the DNA sequencing. Also disclosed are a synthesis and screening reagent testing kit for the lead compound and a combinatorial chemistry library.